Los Angeles Capital Management
CBST

Los Angeles Capital Management’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

Los Angeles Capital Management’s Portfolio CBST Stock Details CBST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-3,506
Closed -$256K – 1363
2014
Q1 		$256K Hold
3,506
– – ﹤0.01% 1113
2013
Q4 		$241K Sell
3,506
-4,820
-58% -$312K ﹤0.01% 1161
2013
Q3 		$529K Sell
8,326
-4,555
-35% -$275K 0.01% 902
2013
Q2 		$622K Buy
+12,881
New +$633K 0.01% 834

Other funds holding CBST

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Los Angeles Capital Management's CBST Position: Q2 2014 in Review

Los Angeles Capital Management sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q2 2014, closing a stake of 3,506 shares — an estimated $256K sold.

Los Angeles Capital Management first reported a position in CBST in Q2 2013 and held it in 4 quarters. The position peaked at $622K in Q2 2013. 270 funds tracked by Wall St. Rank hold CBST as of Q2 2014.

  • Los Angeles Capital Management reported no remaining CUBIST PHARMACEUTICALS INC position as of Q2 2014 after selling out during the quarter.
  • Los Angeles Capital Management sold 3,506 CUBIST PHARMACEUTICALS INC shares in Q2 2014, an estimated $256K.
  • Los Angeles Capital Management first reported a position in CUBIST PHARMACEUTICALS INC in Q2 2013 and held it in 4 quarters.
  • Los Angeles Capital Management's CUBIST PHARMACEUTICALS INC position peaked at $622K in Q2 2013.
  • 270 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q2 2014.

Based on Los Angeles Capital Management's 13F filing for Q2 2014, filed 12 Aug 2014.